Homocysteine and human reproduction

Clinical and Experimental Obstetrics and Gynecology

Volumn 27, Issue 3-4, 2000, Pages 157-167

  Eskes, T K A B ^a   Hon, F F ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ACTIVATED PROTEIN C; ANTITHROMBIN III; BLOOD CLOTTING FACTOR 5 LEIDEN; DNA; FOLIC ACID; HOMOCYSTEINE; MESSENGER RNA; METHYL GROUP; PROTEIN C; PROTEIN S; VITAMIN B GROUP;

AMINO ACID METABOLISM; CELL PROLIFERATION; CLINICAL FEATURE; DNA SYNTHESIS; EMBRYO; EMBRYO DEVELOPMENT; FEMALE; FOLATE METABOLISM; HUMAN; HYPERHOMOCYSTEINEMIA; MESSENGER RNA SYNTHESIS; MISSENSE MUTATION; NEURAL TUBE DEFECT; PREECLAMPSIA; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; SOLUTIO PLACENTAE; VEIN THROMBOSIS; VITAMIN BLOOD LEVEL;

CULTURE TECHNIQUES; FEMALE; FOLIC ACID; HISTORY, 17TH CENTURY; HISTORY, 20TH CENTURY; HOMOCYSTEINE; HUMANS; METHIONINE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MUTATION; NEURAL TUBE DEFECTS; OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; PREGNANCY; REPRODUCTION;

EID: 0034483208     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (97)

1. Prevention of neural-tube defects with folic acid in China. China-US Collaborative Project for Neural Tube Prevention
2. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: Implications for cancer and neuronal damage
3. Treatment of hyperhomocysteinemia in renal transplant recipients: A randomized, placebo-controlled trial
4. Effects of folic acid and vitamin B12 on plasma homocysteine concentrations in healthy young women
5. Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial
6. A methylenetetrahydrofolate reductase polymorphism and the risk of colorectal cancer
7. MTHFR polymorphism, methyl-replete diets and the risk of colorectal carcinoma and adenoma among US men and women: An example of gene-environment interactions in colorectal tumorigenesis
8. Hyperhomocysteinemia: An independent risk factor for vascular disease
9. Lowering blood homocysteine with folic acid based supplements meta-analysis of randomised trials
10. Whole rat embryos require methionine for neural tube closure when cultured on cow serum
11. Haemostatic and metabolic abnormalities in women with unexplained recurrent abortion
12. Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation
13. Folate intake in Europ: Recommended, actual and desired intake
14. Spina bifida 677 C-T mutation and role of folate
15. Preeclampsia and genetic risk factors for thrombosis: A case-control study
16. Underlying disorders associated with severe early-onset preeclampsia
17. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis
18. The synthesis of an octapeptide amide with the hormonal activity of oxytocin
19. Thermolabile 5,10 methylenetetrahydrofolate reductase as a cause of mild hyperhomocysteinemia
20. Open or closed? A world of difference: A history of homocysteine research
21. Germ line polymorphism in cytochrom-P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility
22. Methionine metabolism in mammals
23. Analysis of the 677 C-T mutation of the methylenetetrahydrofolate reductase gene in different ethnic groups
24. Impaired folic absorption in inflammatory bowel disease: Effects of salicylazosulfapyradine (Azulfidine)
25. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
26. Hyperhomocysteinemia: A risk factor for placental abruption or infarction
27. Plasma homocysteine as a risk factor for vascular disease
28. Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to preeclampsia
29. Inositol prevents folate resistant neural tube defects in the mouse
30. Determinants and vitamin responsiveness of intermediate hyperhomocysteinemia (> or = 40 micromol/liter). The Hordaland Homocysteine Study
31. Folic acid and human embryopathy
32. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations
33. Abnormal folate metabolism and mutation in the methyltetrahydrofolate reductase gene may be maternal risk factors for Down syndrome
34. Intermediate homocysteinemia: A thermolabile variant of methylenetetrahydrofolate reductase
35. Congenital heart defects and derangement of homocysteine metabolism
36. Increased frequency of genetic thrombophilia in women with complications of pregnancy
37. The effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis
38. Double-blind randomised control trial of folate treatment before conception to prevent recurrence of neural-tube defects
39. Effects of folic acid on women with hyperhomocysteinemia and a history of preeclampsia and fetal growth retardation
40. Methylenetetrahydrofolate reductase polymorphism, dietary interactions, and risk of colorectal cancer
41. Reduction of plasma homocyst(e)ine by breakfast cereal fortified with folic acid in patients with coronary heart disease
42. The effects of folic acid supplementation on plasma homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes
43. Folate status: Effect on carcinogenesis
44. The stomach in pernicious anemia: A cytologic study
45. Homocysteine metabolism in pregnancies complicated by neural-tube defects
46. Effects of methionine on the cytoplasmatic distribution of actin and tubulin during neural tube closure in rat embryos
47. Thermolabile variant of 5,10 methylenetetrahydrofolate reductase associated with low-red-cell folates: Implications for folate intake recommendations
48. Periconceptional vitamin profiles are not suitable for identifying women at risk for neuroal tube defects
49. Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study
50. Recurrent early pregnancy loss and genetic-related disturbances in folate and homocysteine metabolism
51. Genetic risk factor for unexplained recurrent early pregnancy loss
52. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriage
53. Homocysteine and folate levels as risk factors for recurrent early pregnancy loss
54. Maternal hyperhomocysteinemia and chorionic vascularization in recurrent early pregnancy loss
55. Controlled dietary folate affects folate status in nonpregnant women
56. Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclamptic cohort
57. Hyperhomocysteinemia - A risk factor for abruptio placentae
58. Methylenetetrahydrofolate reductase and neural tube defects
59. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation
60. A woman with five consecutive fetal deaths: Case report and retrospective analysis of hyperhomocysteinemia prevalence in 100 consecutive women with recurrent miscarriage
61. Elevated homocyst(e)ine levels with preeclampsia
62. Plasma homocyst(e)ine concentrations in eclamptic and preeclamptic African women postpartum
63. Folic acid and homocyst(e)ine metabolic defects and the risk of placental abruption, preeclampsia and spontaneous pregnancy loss: A systematic review
64. Folate and homocysteine metabolism and gene polymorphism in the etiology of Down Syndrome
65. Homocysteine induces congenital defects of the heart and neural tube: Effect of folic acid
66. Inhibition of folate enzymes of sulfasalazine
67. Possible prevention of neural tube defects by periconceptional vitamin supplementation
68. Further experience vitamin supplementation for prevention of neural tube defect recurrences
69. Methylenetetrahydrofolate reductase polymorphism and preeclampsia
70. Elevated second-trimester serum homocyst(e)ine levels and subsequent risk of preeclampsia
71. Neural-tube defects and derangement of homocysteine metabolism
72. Hyperhomocysteinemia and recurrent spontaneous abortion or placental abruption
73. Maternal hyperhomocysteinemia: A risk factor for neural-tube defects
74. Serum levels of folate and cobalamin in women with recurrent spontaneous abortion
75. Three different methods for the determination of total homocysteine in plasma
76. Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis
77. Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells
78. Prevention of neural tube defects by and toxicity of L-homocysteine in cultured postimplantation rat embryos
79. Development of methionine synthase, cystathionine-β-synthase, and S-adenosylhomocysteine hydrolase during gestation in the rat
80. Methionine loading test is necessary for detection of hyperhomocysteinemia
81. The effect of folic acid on the homocysteine metabolism on human umbilical vein endothelial cells (HUVEC's)
82. A common mutation in the 5,10 methylenetetrahydrofolate reductase gene as a new risk factor for placental vasculopathy
83. Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida
84. Altered folate and vitamin B12 metabolism in families with spina bifida offspring
85. Is the common 677C-T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects?
86. A second common mutation in the Methylenetetrahydrofolate Reductase gene; a risk factor for neural tube defects?
87. Cervical cytologic abnormalities caused by folic acid deficiency
88. Prothrombin 20210 GA-mutation in women with a history of severe preeclampsia and (H)ELLP syndrome
89. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity
90. MTHFR 677 C-T mutation, folate intake, neural tube-defect, and risk of cardiovascular disease
91. Nonsyndromic orofacial clefts association with maternal hyperhomocysteinemia
92. Hyperhomocysteinemia: A risk factor in women with unexplained recurrent early pregnancy loss
93. Prenatal folic acid treatment suppresses acrania and meroanencephaly in mice mutant for the Cart 1 homeobox gene